Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
ClinicalTrials.gov study NCT06891144. IPD Sharing: NO. Countries: 1. Publications: 0.
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00242515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada
ClinicalTrials.gov study NCT05424562. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06969430. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05682170. IPD Sharing: NO. Countries: 1. Publications: 0.
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05143996. IPD Sharing: NO. Countries: 1. Publications: 0.
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03896854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05241093. IPD Sharing: NO. Countries: 1. Publications: 0.
BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03127735. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04964518. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
ClinicalTrials.gov study NCT04637009. IPD Sharing: NO. Countries: 2. Publications: 0.
A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01305499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
ClinicalTrials.gov study NCT07211958. IPD Sharing: NO. Countries: 2. Publications: 0.
Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05744739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02078609. IPD Sharing: NO. Countries: 7. Publications: 0.
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00402558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06345365. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)
ClinicalTrials.gov study NCT05223699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
ClinicalTrials.gov study NCT00860639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
ClinicalTrials.gov study NCT06811233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.